Recombinant SARS-CoV-2 envelope Protein with His and Avi tag | RP01263LQ

Product Overview:

Recombinant SARS-CoV-2(2019-nCoV) envelope Protein is produced by E. coli expression system. The target protein is expressed with sequence (Met1-Val75) of SARS-COV-2(2019-nCoV) envelope (Accession #QHD43418.1) fused with an initial Met,a 6×His,Avi tag at the N-terminus.

Bioactivity:

Measured by its binding ability in a functional ELISA. Immobilized Recombinant SARS-CoV-2 Envelope at 2ug/mL (100 uL/well) can bind Recombinant SARS-CoV-2 Nucleocapsid with a linear range of 1.2-41.1 ng/mL.

Source:

SARS-CoV-2

Shipping Conditions:

Dry ice